Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML
早期启动低剂量吉瑞替尼维持治疗可改善复发/难治性FLT3突变型急性髓系白血病患者的移植后预后。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2022008991
Terao, Toshiki; Matsuoka, Ken-Ichi; Ueda, Hiroko; Matsumura, Akifumi; Matsubara, Chisato; Kondo, Kaho; Kondo, Takumi; Fujiwara, Hideaki; Asada, Noboru; Ennishi, Daisuke; Nishimori, Hisakazu; Fujii, Keiko; Fujii, Nobuharu; Maeda, Yoshinobu